3 ASX Stocks Near Their 52-Week Highs: Are They Still Worth Buying?

Top 3 ASX stocks trading at 52 week highs supported by strong fundamentals and recent results.

PYC Therapeutics Limited (ASX: PYC)

One of the top healthcare ASX stocks trading near its 52 week highs with a market capitalisation of $2.25B.

PYC has announced on 31 August 2026, in its clinical safety data presentation regarding its PYC-003 drug, which addresses the underlying cause of Polycystic Kidney Disease (PKD) through clinical trials. PYC has reported favourable Phase 1a/1b safety data, including no treatment-related serious adverse event, no changes in serum electrolytes or creatinine, no changes in liver function tests and no evidence of renal injury.

PYC is now progressing towards a multiple ascending stage, with Phase 1a data expected to be presented in CY26 and Phase 1b data in 2027, while targeting a combined Phase 2/3 registrational study afterwards.

PYC had announced on 28 August 2026 its financial report for the year ended on 30 June 2026. Income from ordinary activities increased by 51.6% to $39.7M, and net tangible assets per ordinary security reached 70.13 cents from 28.56 cents in the previous period.

Viva Energy Group Limited (ASX: VEA)

One of the top energy-based ASX stocks, which is trading near its 52 week highs, with a market capitalisation of $4.99B and a current annual fully franked dividend yield of 3.83%.

VES has announced 25 August 2026, its half yearly results for the period ended on June 2026. Group fuel sales increased by 1.3% YoY to 8.5 billion litres, driven by C&M fuel sales (+2% YoY). GRM increased by 156% YoY to US$21.1B, led by Middle Eastern conflict elevating regional refining margins. The shop margin remains stable at 37.7%, and execution of the new supply chain is on track.

VES reported EBITDA of $774M, a growth of 154% YoY, delivering strong performance driven by refining and higher sales. NPAT grew by a massive 492.8% YoY to 371.1M, as higher EBITDA flowed through to NPAT.

Viva Energy has done a net capex of $123M and has a net debt of $1.7B, highlighting strong conversion of earnings to cash. VES announced a fully franked dividend of 7.73 cps, representing a 70% payout ratio of C&M and C&I 1H26 NPAT.

New Hope Corporation Limited (ASX: NHC)

One of the top energy stocks on ASX, which is trading near its 52 week highs with a market capitalisation of 5.15B.

NHC had announced, on 17 August 2026, its quarterly activities report for the period ended on July 2026. The ROM strip ratio was 3.4x bcm/t, and ROM coal production rose to 4.7 million tonnes, an increase of 11.3% QoQ. Saleable coal production increased by 1.6% QoQ to 3.05 million tonnes, with coal sales of 3.02 million tonnes and product stock of 564k tonnes.

NHC’s Bengalla Mine achieved an FOB cash cost (excluding state royalties) of $81.3 per sales tonne for the 2026 financial year, aligned to the low end of guidance. An average realised sales price of $155.8/t sq. was achieved for the quarter, an increase of 10.7% QoQ.

NHC reported underlying EBITDA of $169.3M (+30.1% QoQ) and $514.3M for the financial year. Cash generated from operating activities was $564.1M for the 2026 financial year, with available cash of $778.5M as of 31 July 2026.

Conclusion

These three ASX stocks are trading near 52 week highs, led by strong business development, pipeline expansion, strong results and a stable future outlook. The PYC's recent announcement reduces the clinical risk and increases the economic viability in the long run. VEA has demonstrated performance in the recent results supported by growth across different line items of financials from revenue to earnings to cash flow, highlighting the fundamental strength of the company. NHC also delivers a strong quarter and full-year results, meeting or exceeding the management guidance for FY26.

(Source: Company Announcements)